The National Institutes of Health will spend about $1.1 billion this year on research to prevent and treat opioid addiction, NIH Director Francis Collins, M.D., announced today. The Helping to End Addiction Long-term Initiative will study patients after acute onset of musculoskeletal pain and after surgery to identify biomarkers that might predict those more likely to transition from acute to chronic pain; genetic and social factors that put patients at risk for opioid misuse and addiction; and best practices for pain management using nondrug and integrated therapies for specific pain conditions. It also will pursue public-private partnerships to develop new non-addictive pain medicines; build a clinical trials network to allow multiple compounds to be tested simultaneously for effectiveness; research additional treatment options for addiction and neonatal opioid withdrawal syndrome; and test prevention and treatment options in health care and criminal justice settings in states with the highest opioid misuse and overdose rates.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.